Blood
collection devices plays a crucial role in the patient treatment. For
the treatment, blood samples are collected to measure the basic
metabolism components such as blood urea nitrogen, sodium, potassium,
creatinine, magnesium, chloride, and also used to measure blood
glucose and lipid levels. In the recent years, as technology has
increased in availability and complexity, the experts in the
laboratories are receiving wide range of opportunities and
challenges. In case of opportunity, automated method of collection
enables technologists to perform a greater variety of tests on
smaller sample quantities with greater accuracy of outcomes than the
manual blood collection process. Therefore, there is an increasing
number of laboratories taking their pace in the market from their
hematology and chemistry analyzers to automated platforms.
Request
a Sample Copy of Blood Collection Devices Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1160
Increasing
prevalence of certain disease conditions such as cancer, HIV/AIDS,
diabetes, coronary heart disease, and anemia are the driving factor
for the growth of the blood collection devices market. In addition,
increasing numbers of surgeries and high demand for blood transfusion
and casualty cases are further driving the growth of blood collection
devices market. According to the Centers for Disease Control and
Prevention (CDC), the U.S. reported 26,203 cases of Lyme disease for
the period between 2006 and 2016. According to the same source,
around 10,265 deaths were reported due to alcohol-impaired crashes in
2015 which accounted for around 29% of all traffic-related deaths in
the U.S.
Continuous
product advancement in blood collection devices fuel the growth of
the market
Tasso,
Inc., a company engaged in the manufacture of HemoLink, a simplified
blood collection device used in the various diagnostic application
received the US$ 3 million funding from Defenses Advanced Research
Projects Agency (DARPA) to advances their HemoLink technology by
collaborating with GenTegra LLC, a company engaged in the manufacture
of product used in the biopreservation, biobanking and in vitro
diagnostics. Moreover the continuous product development and future
advances in the blood collection techniques are expected to propel
the growth of blood collection devices market.
Key
players in the blood collection devices market:
Some
of the key players in the blood collection devices market includes
Becton, Dickinson and Company, NIPRO Medical Corporation, Terumo
Medical Corporation, Medtronic plc, Qiagen, Bio-Rad Laboratories,
Inc., Haemonetics Corporation, and Fresenius SE & Co. KGaA.
Blood
Collection Devices Market Taxonomy:
On
the basis of type, blood collection devices market segmented into:
-
Blood collection tubes
-
Serum collection tubes
-
Plasma collection tubes
-
Heparin tubes
-
Other tubes (EDTA, ESR and Microcapillary tubes
-
Needles & syringes
-
Lancets
-
Vacuum blood collection system
-
Microfluidic system
-
Blood bags
-
Accessories
Browse
In-Depth Analysis Research Report @
https://www.coherentmarketinsights.com/ongoing-insight/blood-collection-devices-market-1160
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment